Global Colon Cancer Association shared on LinkedIn:
“Meet our newest Global CRC Congress speaker, Helena Harnik.
Helena is Programs Executive Director at The Synergist.org and Executive Director of the From Testing to Targeted Treatments (FT3) Program, where she works to help bridge the gap between biomarker testing and access to targeted treatments
Through FT3, Helena brings diverse people and organizations together to address barriers to precision medicine and help move from testing to treatment.
We’re excited to have Helena join global experts, healthcare professionals, and advocates at the 2026 Global CRC Congress for conversations on improving colorectal cancer care and access around the world.
Join us virtually November 5–6, 2026.
Registration is free and includes access to live sessions and recordings.
Register now: Global Colorectal Cancer Congress.”
Other articles about Global Colon Cancer Association on OncoDaily.